文献速递心力衰竭与心肌病

心力衰竭中的姑息治疗:PAL-HF随机对照临床试验

Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial.
PubMed 文献 · J Am Coll Cardiol · 2017-01-01

PAL-HF试验将150例晚期心衰患者随机分为常规治疗组和常规治疗联合跨学科姑息治疗干预组,评估6个月时生活质量、抑郁焦虑、精神健康及再住院和死亡。结果显示联合干预组在生活质量、抑郁、焦虑和精神健康方面均优于常规治疗组,但未影响再住院或死亡。

要点

  • 晚期心衰患者在常规治疗基础上加用跨学科姑息治疗可改善6个月生活质量。
  • 联合姑息治疗可改善抑郁、焦虑和精神健康,但不影响再住院或死亡。
  • 姑息治疗应作为晚期心衰综合管理的一部分,与循证心衰治疗联合使用。

核心结论

  • 在晚期心衰患者中,跨学科姑息治疗干预联合常规治疗在生活质量、焦虑、抑郁和精神健康方面持续优于单独常规治疗。

研究设计与样本

  • 单中心随机对照试验,纳入150例晚期心衰患者,随机分为常规治疗组(n=75)和常规治疗联合姑息治疗干预组(n=75),随机化时间为2012年8月15日至2015年6月25日。

主要发现

  • 从随机化到6个月,联合干预组较常规治疗组KCCQ评分改善9.49分(95%CI:0.94至18.05,p=0.030)。
  • 从随机化到6个月,联合干预组较常规治疗组FACIT-Pal评分改善11.77分(95%CI:0.84至22.71,p=0.035)。
  • 联合干预组抑郁改善(HADS-抑郁差异=-1.94分,p=0.020),焦虑改善(HADS-焦虑差异=-1.83分,p=0.048)。
  • 联合干预组精神健康改善(FACIT-Sp差异=3.98分,p=0.027)。
  • 随机分配到联合干预组未影响再住院或死亡。

临床怎么用

  • 对晚期心衰患者,可在循证心衰治疗基础上联合跨学科姑息治疗以改善生活质量和心理精神症状。
  • 姑息治疗干预不应以降低再住院或死亡为主要预期目标。

局限性

  • 单中心研究,样本量150例,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Advanced heart failure (HF) is characterized by high morbidity and mortality. Conventional therapy may not sufficiently reduce patient suffering and maximize quality of life. OBJECTIVES: The authors investigated whether an interdisciplinary palliative care intervention in addition to evidence-based HF care improves certain outcomes. METHODS: The authors randomized 150 patients with advanced HF between August 15, 2012, and June 25, 2015, to usual care (UC) (n = 75) or UC plus a palliative care intervention (UC + PAL) (n = 75) at a single center. Primary endpoints were 2 quality-of-life measurements, the Kansas City Cardiomyopathy Questionnaire (KCCQ) overall summary and the Functional Assessment of Chronic Illness Therapy-Palliative Care scale (FACIT-Pal), assessed at 6 months. Secondary endpoints included assessments of depression and anxiety (measured via the Hospital Anxiety and Depression Scale [HADS]), spiritual well-being (measured via the FACIT-Spiritual Well-Being scale [FACIT-Sp]), hospitalizations, and mortality. RESULTS: Patients randomized to UC + PAL versus UC alone had clinically significant incremental improvement in KCCQ and FACIT-Pal scores from randomization to 6 months (KCCQ difference = 9.49 points, 95% confidence interval [CI]: 0.94 to 18.05, p = 0.030; FACIT-Pal difference = 11.77 points, 95% CI: 0.84 to 22.71, p = 0.035). Depression improved in UC + PAL patients (HADS-depression difference = -1.94 points; p = 0.020) versus UC-alone patients, with similar findings for anxiety (HADS-anxiety difference = -1.83 points; p = 0.048). Spiritual well-being was improved in UC + PAL versus UC-alone patients (FACIT-Sp difference = 3.98 points; p = 0.027). Randomization to UC + PAL did not affect rehospitalization or mortality. CONCLUSIONS: An interdisciplinary palliative care intervention in advanced HF patients showed consistently greater benefits in quality of life, anxiety, depression, and spiritual well-being compared with UC alone. (Palliative Care in Heart Failure [PAL-HF]; NCT01589601).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Rogers JG, Patel CB, Mentz RJ, et al. Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial. J Am Coll Cardiol. 2017. PMID: 28705314. doi:10.1016/j.jacc.2017.05.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。